Skip to main content
. 2017 Mar 15;37(5):2663–2671. doi: 10.3892/or.2017.5509

Figure 5.

Figure 5.

Methylation rate of the Wnt5a promoter in AML patients and normal controls (pyrophosphate sequencing). AML, acute myeloid leukemia.